CheckmAb and Boehringer Ingelheim Collaborate to Develop Novel Immunotherapy for Cancer Patients
Milan, Italy 22 March 2023 – CheckmAb S.r.l. announces a collaboration and license agreement with Boehringer Ingelheim to develop a new
Xyence sells its stake in AnaBios Corporation
07 giugno 2022 – Xyence Capital SGR S.p.A. (“Xyence”) cede la sua quota (22,8%) in AnaBios Corporation – Contract Research Organization (“CRO”) statunitense attiva nei
Evotec acquires 100% of the capital of Rigenerand
May 30, 2022 - Xyence Capital SGR S.p.A. sells its stake (50.2%) in the share capital of Rigenerand S.r.l. - a leading Italian ...
Apposite Capital acquires majority stake in CrestOptics
November 11, 2021 - CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems ...
Gada joins Palex
March 23, 2022 - Xyence Capital SGR sells its stake (65%) in the share capital of Gada S.p.A - Italy's leading ...